Patienter med mild nyreinsufficiens havde ikke en klinisk relevant stigning i plasmakoncentrationen af sitagliptin sammenlignet med de normale raske kontrolpersoner.
Patients with mild renal insufficiency did not have a clinically meaningful increase in the plasma concentration of sitagliptin as compared to normal healthy control subjects.